Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

CALT
Calliditas Therapeutics AB
stock NASDAQ

Inactive
Sep 20, 2024
40.00USD-0.398%(-0.16)9,796
Pre-market
0.00USD-100.000%(-40.16)0
After-hours
0.00USD0.000%(0.00)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 28, 2022
02:17AM EST  Calliditas Therapeutics Announces Commercial Availability And Initial Sales Of TARPEYO   RTTNews
02:15AM EST  Calliditas Therapeutics Announces Commercial Availability and Initial Sales of   PR Newswire
Dec 20, 2021
07:25AM EST  The following are some of the stocks making big moves in Monday's pre-market trading (as of 07.10 A.M. ET).   RTTNews
07:19AM EST  10 Biggest Price Target Changes For Monday   Benzinga
06:23AM EST  HC Wainwright & Co. Maintains Buy on Calliditas Therapeutics, Raises Price Target to $62   Benzinga
Dec 19, 2021
12:54PM EST  The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week   Benzinga
Dec 16, 2021
02:31PM EST  Mid-Afternoon Market Update: Nasdaq Down 2.5%; Calliditas Therapeutics Shares Spike Higher   Benzinga
12:23PM EST  Mid-Day Market Update: Gold Rises 2%; IronNet Shares Plummet   Benzinga
10:24AM EST  Mid-Morning Market Update: Markets Mixed; Accenture Beats Q1 Estimates   Benzinga
08:20AM EST  The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street   Benzinga
Dec 15, 2021
10:13PM EST  FDA Grants Calliditas Accelerated Approval Of Tarpeyo To   RTTNews
05:05PM EST  FDA grants Calliditas Therapeutics Accelerated Approval of TARPEYO(tm)   PR Newswire
04:26PM EST  Calliditas Says FDA Grants Co Accelerated Approval Of TARPEYO To Reduce Proteinuria In IgA Nephropathy   Benzinga
08:03AM EST  The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO   Benzinga
Dec 12, 2021
04:56PM EST  The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More   Benzinga
Dec 2, 2021
12:02PM EST  Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates   Benzinga
Nov 18, 2021
07:06AM EST  Calliditas Therapeutics: Q3 Earnings Insights   Benzinga
05:01AM EST  Earnings Scheduled For November 18, 2021   Benzinga
01:25AM EST  Calliditas Therapeutics Q3 Operating Profit SEK 7.9 Mln Vs. Operating Loss SEK 104.9 Mln Prior Year   RTTNews
01:13AM EST  Calliditas Therapeutics: Interim Report Q3, 2021   PR Newswire
Nov 3, 2021
04:41AM EDT  Calliditas announces poster presentations at ASN Digital Kidney Week 2021   PR Newswire
Nov 2, 2021
05:18AM EDT  Calliditas Therapeutics' nomination committee for the AGM 2022   PR Newswire
Oct 7, 2021
08:24AM EDT  The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results   Benzinga
02:22AM EDT  Calliditas announces acquisition of remaining Genkyotex minority shares   PR Newswire
Oct 1, 2021
02:29PM EDT  Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates   Benzinga
Sep 19, 2021
09:46AM EDT  The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions and Conference Presentations In The Spotlight   Benzinga
Sep 16, 2021
08:54AM EDT  Calliditas Therapeutics Announces European Medicine Agency's Committee For Human Medicinal Products Has Decided To 'continue the assessment of the marketing authorization application (MAA) for Nefecon under standard procedure assessment timelines.'   Benzinga
08:53AM EDT  Updated regulatory timeline for review of MAA in Europe   PR Newswire
Sep 15, 2021
07:38AM EDT  The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs   Benzinga
06:43AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 6.10 A.M. EDT).   RTTNews
Sep 14, 2021
05:29PM EDT  Calliditas Therapeutics Announces FDA Has Extended PDUFA Goal Date For Nefecon   Benzinga
05:27PM EDT  PDUFA goal date extension for Nefecon NDA in the U.S.   PR Newswire
Sep 12, 2021
04:04PM EDT  The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs   Benzinga
Aug 31, 2021
02:41AM EDT  Number of shares and votes in Calliditas Therapeutics   PR Newswire
Aug 19, 2021
07:34AM EDT  Calliditas Therapeutics Earlier Reported Q2 EPS $(0.38) Beats $(0.48) Estimate   Benzinga
04:04AM EDT  Earnings Scheduled For August 19, 2021   Benzinga
01:28AM EDT  Calliditas Therapeutics Q2 Loss/shr SEK 3.20 Vs. Loss/shr SEK 1.50 Prior Year   RTTNews
01:20AM EDT  Calliditas Therapeutics: Interim Report Q2, 2021   PR Newswire
Aug 17, 2021
05:52AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.37 A.M. EDT).   RTTNews
Aug 12, 2021
06:45PM EDT  Calliditas Therapeutics has resolved on a directed share issue in the amount of   PR Newswire
Aug 9, 2021
10:57AM EDT  Calliditas' Chronic Orphan Liver Disease Candidate Receives FDA Fast Track Tag   Benzinga
03:20AM EDT  Calliditas: FDA Grants Fast Track Designation For Setanaxib In Primary Biliary Cholangitis   RTTNews
03:14AM EDT  Calliditas Receives FDA Fast Track Designation for setanaxib in PBC   PR Newswire
Jul 21, 2021
06:56AM EDT  Calliditas, STADA Ink Budesonide Commercialization Pact In Europe, UK For Immunoglobulin A Nephropathy   Benzinga
03:10AM EDT  Calliditas Therapeutics And STADA Partner To Commercialize Specialty Therapy For IgA Nephropathy In Europe   RTTNews
03:05AM EDT  Calliditas Therapeutics and STADA partner to register and commercialize   PR Newswire
Jul 15, 2021
03:05AM EDT  Calliditas Therapeutics Signs Loan Agreement Of Up To The Euro Equivalent Of $75 Mln With Kreos Capital   RTTNews
03:02AM EDT  Calliditas secures $75 million term loan facility   PR Newswire
May 28, 2021
09:11AM EDT  Calliditas therapeutics reports Submitted Marketing Authorization Application To EMA For Nefecon For Treatment Of Primary IgA Nephropathy   Benzinga
09:09AM EDT  Calliditas Submits Marketing Authorisation Application For Nefecon To The European Medicines Agency   RTTNews
09:07AM EDT  Calliditas Announces Submission of Marketing Authorisation Application for   PR Newswire
06:13AM EDT  Calliditas Therapeutics to Present at Jefferies Virtual Healthcare Conference   PR Newswire
May 27, 2021
12:46PM EDT  Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)   PR Newswire
May 18, 2021
04:08AM EDT  Earnings Scheduled For May 18, 2021   Benzinga
01:17AM EDT  Calliditas Therapeutics Q1 Loss Per Share SEK 2.51 Vs Loss SEK 1.65 Last Year   RTTNews
01:12AM EDT  Interim Report Q1, 2021   PR Newswire
May 14, 2021
08:13AM EDT  Calliditas Therapeutics to host conference call to provide Business Update for   PR Newswire
May 3, 2021
08:52AM EDT  Calliditas promotes Andrew Udell to President, North America   PR Newswire
Apr 28, 2021
07:26AM EDT  The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping   Benzinga
07:17AM EDT  Calliditas Announces That The FDA Grants Priority Review For Its Nefecon For Patients With IgA Nephropathy   Benzinga
04:37AM EDT  Calliditas Therapeutics: FDA Grants Priority Review For Nefecon For IgA Nephropathy; Sets PDUFA Goal Date Of Sept 15   RTTNews
04:05AM EDT  FDA grants priority review for Nefecon, for patients with IgA nephropathy   PR Newswire
Apr 27, 2021
08:44AM EDT  Calliditas Therapeutics AB: Change in financial calendar   PR Newswire
08:42AM EDT  Calliditas Therapeutics' 2020 Annual Report Published   PR Newswire
Apr 26, 2021
06:30AM EDT  Notice of annual general meeting of Calliditas Therapeutics AB (publ)   PR Newswire
Apr 23, 2021
07:28AM EDT  The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs   Benzinga
04:55AM EDT  Calliditas Therapeutics: EMA Grants Accelerated Assessment Procedure For Nefecon For IgA Nephropathy   RTTNews
02:56AM EDT  EMA Grants Accelerated Assessment Procedure for Nefecon for the Treatment of   PR Newswire
Mar 15, 2021
06:45AM EDT  Calliditas Therapeutics Files US Application For Nefecon In Kidney Disease   Benzinga
05:33AM EDT  Calliditas Announced Submission of NDA to FDA for Nefecon in Patients with Primary IgA Nephropathy   Benzinga
02:59AM EDT  Calliditas Announces Submission of New Drug Application to U.S. FDA for Nefecon   PR Newswire
Mar 8, 2021
02:54AM EST  Calliditas strengthens its US Commercial and Medical Affairs Organization   PR Newswire
Mar 4, 2021
09:13AM EST  Calliditas Therapeutics to Host Key Opinion Leader Perspectives Webinar on the   PR Newswire
Feb 18, 2021
04:28AM EST  Earnings Scheduled For February 18, 2021   Benzinga
01:11AM EST  Calliditas Therapeutics: Year-End Report, 2020   PR Newswire
Feb 4, 2021
08:05AM EST  Calliditas Starts Dosing In Nefecon Open Label Extension Study In Kidney Disease   Benzinga
03:07AM EST  Calliditas Therapeutics Doses First Patient In Phase 3 NefIgArd Open Label Extension Study   RTTNews
02:47AM EST  First Patient Dosed in NefIgArd Open Label Extension Study   PR Newswire
Jan 28, 2021
09:14AM EST  Calliditas Announces Termination Of The Proposed Global Offering   Benzinga
Jan 26, 2021
04:57PM EST  Calliditas Therapeutics launches proposed global offering   PR Newswire
Jan 21, 2021
02:47AM EST  Calliditas Therapeutics Says All 360 Patients Enrolled For Global Phase 3 Clinical Trial NefIgArd   RTTNews
02:44AM EST  Calliditas Announces Full Enrollment of the Phase 3 NefIgArd Trial   PR Newswire
Jan 20, 2021
07:32AM EST  The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study   Benzinga
02:16AM EST  Calliditas Announces Clinical Development Plan For Setanaxib   RTTNews
02:14AM EST  Calliditas announces clinical development plan for setanaxib and comments on   PR Newswire
Jan 18, 2021
02:41AM EST  Genkyotex Announces Positive Phase 1 Data In In High-dose Setanaxib Trial   RTTNews
02:12AM EST  Positive Phase 1 results in high-dose setanaxib trial   PR Newswire
Jan 15, 2021
03:45AM EST  Agenda for Calliditas virtual R&D Day on January 20, 2021   PR Newswire
Dec 16, 2020
11:57AM EST  Calliditas announces final outcome of simplified mandatory offer to the   PR Newswire
Dec 10, 2020
02:13AM EST  Calliditas wins the 2020 SwedenBio Award   PR Newswire
Dec 9, 2020
07:15AM EST  Save the date: Calliditas to host a Capital Markets Day in Stockholm, Sweden,   PR Newswire
Dec 1, 2020
06:30PM EST  Everest Medicines Announces The China Center for Drug Evaluation,   GlobeNewswire Inc
03:05AM EST  The lockup period of Calliditas Therapeutics AB (publ) (CALT) expires tomorrow (December 2).   RTTNews
Nov 27, 2020
10:13AM EST  Calliditas Therapeutics' nomination committee for the AGM 2021   PR Newswire
Nov 12, 2020
04:18AM EST  Earnings Scheduled For November 12, 2020   Benzinga
01:33AM EST  Interim Report Q3, 2020   PR Newswire
Nov 11, 2020
05:31AM EST  Calliditas Therapeutics to host conference call to provide Business Update and   PR Newswire
Nov 10, 2020
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 9, 2020
10:52AM EST  Shares of Calliditas Therapeutics AB (CALT) surged over 30% on Monday morning after the company announced positive topline results from a pivotal late-stage study of a chronic kidney disease treatment.   RTTNews
05:50AM EST  Calliditas Announced Sunday Pivotal Phase 3 NefIgArd Trial Met Primary Objective; To Host Conference Call at 8:30 AM ET   Benzinga
05:49AM EST  Calliditas Announced Sunday Pivotal Phase 3 NefIgArd Trial Met Primary; To Host Conference Call at 8:30 AM ET   Benzinga
04:13AM EST  Calliditas Therapeutics to host conference call on positive topline results   PR Newswire
Nov 8, 2020
11:52PM EST  Calliditas Announces Positive Topline Results From Pivotal Phase 3 NefIgArd Trial   RTTNews
11:48PM EST  Calliditas Announces Positive Topline Results from Pivotal Phase 3 NefIgArd   PR Newswire
Nov 3, 2020
09:25AM EST  Calliditas closes acquisition of a controlling interest in Genkyotex SA   PR Newswire
Oct 19, 2020
02:14AM EDT  Calliditas Announces Poster and Presentation at ASN Digital Kidney Week 2020   PR Newswire
Oct 1, 2020
04:01AM EDT  The 200th patient's last visit completed in Part A of NefIgArd supporting   PR Newswire
Sep 30, 2020
04:14AM EDT  Number of shares and votes in Calliditas Therapeutics   PR Newswire
Sep 8, 2020
02:48AM EDT  Calliditas Therapeutics Says First Patient In China Enrolled In Clinical Phase 3 Study NefIgArd With Nefecon   RTTNews
02:12AM EDT  First patient in China enrolled in clinical phase 3 study NefIgArd with lead   PR Newswire
Aug 25, 2020
02:21AM EDT  Calliditas appoints Group General Counsel   PR Newswire
Aug 13, 2020
04:03AM EDT  Earnings Scheduled For August 13, 2020   Benzinga
02:01AM EDT  Calliditas To Buy 62.7% Of Genkyotex For 20.3 Mln In Cash At 2.80/shr In Off-market Transaction   RTTNews
01:37AM EDT  Calliditas Therapeutics: Interim Report Q2, 2020   PR Newswire
01:23AM EDT  Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA   PR Newswire
Aug 11, 2020
08:17AM EDT  Calliditas Therapeutics to host conference call to provide Business Update and   PR Newswire
Jul 31, 2020
06:25AM EDT  Number of shares and votes in Calliditas Therapeutics   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC